|
|
|
Volumn 5, Issue 10, 1999, Pages 2672-2673
|
|
Dihydropyrimidine dehydrogenase: Its role in 5-fluorouracil clinical toxicity and tumor resistance
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIHYDROPYRIMIDINE DEHYDROGENASE;
FLUOROURACIL;
SORIVUDINE;
CANCER;
CANCER RESISTANCE;
CONTINUOUS INFUSION;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG EFFECT;
DRUG METABOLISM;
EDITORIAL;
ENZYME ACTIVITY;
ENZYME DEFICIENCY;
HUMAN;
PHARMACOGENETICS;
PRIORITY JOURNAL;
SIDE EFFECT;
ANTIMETABOLITES, ANTINEOPLASTIC;
DIHYDROURACIL DEHYDROGENASE (NADP);
DRUG RESISTANCE, NEOPLASM;
FLUOROURACIL;
HUMANS;
NEOPLASMS;
OXIDOREDUCTASES;
|
|
EID: 0032748608
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (108)
|
|
References (18)
|
